Nektar Therapeutics (NKTR)
NASDAQ: NKTR
· Real-Time Price · USD
0.65
-0.01 (-1.52%)
At close: May 23, 2025, 3:59 PM
0.66
1.88%
After-hours: May 23, 2025, 07:30 PM EDT
-1.52% (1D)
Bid | 0.6 |
Market Cap | 120.56M |
Revenue (ttm) | 87.25M |
Net Income (ttm) | -133.04M |
EPS (ttm) | -0.63 |
PE Ratio (ttm) | -1.03 |
Forward PE | -0.81 |
Analyst | Buy |
Ask | 0.67 |
Volume | 893,403 |
Avg. Volume (20D) | 2,089,676 |
Open | 0.63 |
Previous Close | 0.66 |
Day's Range | 0.62 - 0.65 |
52-Week Range | 0.43 - 1.71 |
Beta | 0.63 |
About NKTR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NKTR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NKTR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+23.76%
Nektar Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
2 months ago
+9.98%
Nekar Therapeutics shares are trading higher after Oppenheimer upgraded the stock from Perform to Outperform and announced a price target of $6.